CIAM
ANAB icon

Caitong International Asset Management’s AnaptysBio ANAB Stock Holding History

Caitong International Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129K Buy
2,329
+799
+52% +$43K 0.02% 509
2025
Q4 		$74.2K Buy
1,530
+1,383
+941% +$53.9K 0.02% 559
2025
Q3 		$4.5K Buy
+147
New +$3.37K ﹤0.01% 1248
2025
Q1 		– Sell
-5
Closed -$66 – 2149
2024
Q4 		$66 Buy
+5
New +$121 ﹤0.01% 1632

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caitong International Asset Management's ANAB Position: Q1 2026 in Review

Caitong International Asset Management increased its AnaptysBio (ANAB) stake by 52% in Q1 2026, buying an estimated $43K and bringing the position to 2,329 shares worth $129K. The position accounts for 0.02% of the portfolio, ranked #509.

Caitong International Asset Management first reported a position in ANAB in Q4 2024 and has held it in 4 quarters since. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Caitong International Asset Management held 2,329 shares of AnaptysBio worth $129K as of Q1 2026.
  • Caitong International Asset Management bought 799 AnaptysBio shares in Q1 2026, an estimated $43K.
  • AnaptysBio made up 0.02% of Caitong International Asset Management's portfolio in Q1 2026, its #509 holding.
  • Caitong International Asset Management first reported a position in AnaptysBio in Q4 2024 and has held it in 4 quarters since.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.